Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,639 | 5,719 | 6,916 | 6,888 | 7,136 |
| Marketable Securities | 10,225 | 8,272 | 8,567 | 9,150 | 10,859 |
| Other current assets | 0 | 0 | 0 | 1,495 | 1,622 |
| TOTAL | $13,428 | $14,602 | $16,386 | $18,322 | $20,303 |
| Non-Current Assets | |||||
| Intangibles | 2,039 | 2,039 | 2,039 | 2,039 | 2,039 |
| Other Non-Current Assets | 32 | 236 | 53 | 63 | 73 |
| TOTAL | $2,071 | $2,275 | $2,092 | $2,102 | $2,112 |
| Total Assets | $15,499 | $16,877 | $18,478 | $20,424 | $22,415 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 889 | 569 | 788 | 958 | 438 |
| TOTAL | $921 | $603 | $825 | $998 | $480 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 6 | 15 | 23 | 32 |
| TOTAL | $N/A | $6 | $15 | $23 | $32 |
| Total Liabilities | $921 | $609 | $840 | $1,021 | $512 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 177 | 160 | 159 | 159 | 159 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -37,237 | -34,788 | -33,189 | -31,021 | -27,682 |
| Other shareholders' equity | -199 | -201 | -205 | -254 | -388 |
| TOTAL | $14,578 | $16,268 | $17,638 | $19,403 | $21,903 |
| Total Liabilities And Equity | $15,499 | $16,877 | $18,478 | $20,424 | $22,415 |